Cargando…
Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis
The basis of treatment for advanced germ cell tumors is chemotherapy and surgical resection of residual disease. Surgery has maintained its role in staging and therapeutic management. Despite these advances, much of the outcomes depend on proper patient selection. Complete removal of all post-chemot...
Autores principales: | Fitzgerald, John P., Ercole, Barbara, Parekh, Dipen J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878447/ https://www.ncbi.nlm.nih.gov/pubmed/20535294 http://dx.doi.org/10.4103/0970-1591.60448 |
Ejemplares similares
-
Management of good-risk metastatic nonseminomatous germ cell tumors of the testis: Current concepts and controversies
por: Jayram, Gautam, et al.
Publicado: (2010) -
Management options for stage 1 nonseminomatous germ cell tumors of the testis
por: Beck, Stephen D. W.
Publicado: (2010) -
Surgical controversies in the management of post-chemotherapy nonretroperitoneal residual disease in metastatic nonseminomatous germ cell tumors
por: Pandey, Durgatosh, et al.
Publicado: (2016) -
Intratumoral heterogeneity and chemoresistance in nonseminomatous germ cell tumor of the testis
por: Bilen, Mehmet Asim, et al.
Publicado: (2016) -
Clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor
por: Blok, Joost M., et al.
Publicado: (2020)